Sprint Bioscience AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	341	136	110	121	39	163
Market Cap Growth	443.77%	23.24%	-8.82%	213.85%	-76.26%	23.12%
Enterprise Value	232.49	9.43	85.4	71.2	9.1	91.97
Last Close Price	3.41	1.47	1.58	1.74	0.55	4.08
PE Ratio	3.92	1.50	-	-	-	-
Forward PE	11.10	5.88	1.76	2.48	11.06	2.01
PS Ratio	2.22	0.81	1.64	2.23	86.35	4.64
PB Ratio	3.21	1.14	11.91	4.36	1.37	2.31
P/TBV Ratio	3.25	1.14	11.91	4.36	0.83	1.67
P/FCF Ratio	4.89	1.63	-	5.93	-	-
P/OCF Ratio	4.89	1.63	-	5.30	-	-
EV/Sales Ratio	1.52	0.06	1.27	1.31	20.37	2.62
EV/EBITDA Ratio	2.61	0.10	-	-	-	-
EV/EBIT Ratio	2.64	0.10	-	-	-	-
EV/FCF Ratio	3.34	0.11	-	3.49	-	-
Net Debt / Equity Ratio	-1.02	-1.06	-2.70	-1.80	-1.05	-1.00
Net Debt / EBITDA Ratio	-1.22	-1.29	1.34	125.46	0.49	2.82
Net Debt / FCF Ratio	-1.54	-1.52	1.02	-2.45	0.50	1.65
Asset Turnover	1.20	1.88	1.29	1.09	0.01	0.62
Quick Ratio	9.10	7.60	1.14	1.67	3.78	8.75
Current Ratio	9.10	7.60	1.14	1.67	3.78	8.75
Return on Equity (ROE)	-14.01%	142.84%	-98.67%	-1.57%	-122.00%	-63.02%
Return on Assets (ROA)	68.84%	108.88%	-37.67%	-1.69%	-104.22%	-45.55%
Return on Invested Capital (ROIC)	2406.07%	2261.53%	-422.20%	-23.99%	-2116.38%	-1184.84%
Return on Capital Employed (ROCE)	78.05%	151.49%	-106.18%	-3.02%	-123.15%	-64.39%
Earnings Yield	24.79%	66.67%	-	-	-	-
FCF Yield	20.45%	61.29%	-	16.85%	-	-
Buyback Yield / Dilution	-45.41%	-32.63%	-0.01%	-65.98%	-45.85%	-81.46%
Total Shareholder Return	-45.41%	-32.63%	-0.01%	-65.98%	-45.85%	-81.46%